Genentech, Herceptin Marketing and Sales Practices Litigation
IN RE: Genentech, Inc., Herceptin (Trastuzumab) Marketing and Sales Practices Litigation
Overview
The Genentech, Herceptin Marketing and Sales Practices Litigation is a federal multidistrict litigation consolidated in the OKN before Gregory K Frizzell (Chief Judge, USDC). This MDL involves claims related to other issues.
As of 2026-05-01, there are 13 pending actions out of 15 total actions filed, representing a 13% resolution rate.
Who May Qualify
Eligibility for this MDL typically depends on factors such as:
- Documented exposure to or use of the product/device in question
- Medical diagnosis of related injuries or conditions
- Claim filed within the applicable statute of limitations
Key Information
Assigned Judge
Gregory K Frizzell (Chief Judge, USDC)
District Court
OKN
MDL Number
MDL-2700
Category
Other
Attorney Advertising. The information on this page is for general informational purposes only and does not constitute legal advice. No attorney-client relationship is formed by reading this content. Results in MDL cases vary widely; past results do not guarantee future outcomes. If you believe you have a legal claim, consult a licensed attorney in your jurisdiction.